Skip to main content
Equibles

Invesco Ltd.

Position in IMVT — Immunovant, Inc.

CIK 914208 Atlanta, GA
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,635,342
+$1,303,017 QoQ
Shares Held
94,351
+0.5% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 226 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 0% Shared 98% None 2%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. IMVT ranks #95 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in IMVT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,635,342 94,351
2026-03-31 $2,332,325 93,894
2025-12-31 $2,258,743 88,857
2025-09-30 $1,234,822 76,602
2025-06-30 $1,068,000 66,750
2025-03-31 $945,280 55,312
2024-12-31 $12,484,870 504,032
2024-09-30 $16,941,837 594,242
2024-06-30 $15,071,706 570,898
2024-03-31 $17,002,586 526,233
2023-12-31 $20,732,803 492,115
2023-09-30 $9,177,319 239,055
2023-06-30 $428,720 22,600
2023-03-31 $248,732 16,037
2022-12-31 $299,299 16,862
2022-09-30 $89,468 16,034
2022-06-30 $63,347 16,243
2022-03-31 $103,036 18,700
2021-12-31 $153,265 17,989
2021-09-30 $181,827 20,924
2021-06-30 $9,111,476 862,013
2021-03-31 $13,792,185 859,862
2020-12-31 $52,078,623 1,127,487
2020-09-30 $8,608,352 244,625
2020-06-30 $3,648,822 149,849